mutant p53 reactivators (Bioleaders)

N/A

Report date: 2025/03/20 15:58:12

NME

Base Information

Drug Namemutant p53 reactivators (Bioleaders)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionTumor protein p53 stimulants

TargetsTumor protein p53

Therapy Area/IndicationsSolid tumoursHematologic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesBL Corp

China Registration ClassN/A

Active CompaniesBL Corp

Inactive CompaniesN/A

Active IndicationsSolid tumoursHematologic Neoplasms

Inactive IndicationsN/A

ATC CodeN/A